Zkusit zdarma
Annexon, Inc.

Annexon, Inc.

ANNX
Cena:
$ 5.31
-0.13 (-2.39%)
Valuace
70
Růst
53
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

16:05 18-05-2026

BRISBANE, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical...

Annexon Highlights Q4 Geographic Atrophy Data, GBS Filing Plans at BofA Conference

Annexon Highlights Q4 Geographic Atrophy Data, GBS Filing Plans at BofA Conference

4:06 14-05-2026

Annexon NASDAQ: ANNX President and CEO Doug Love outlined the company's late-stage pipeline and regu...

Annexon, Inc. (ANNX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Annexon, Inc. (ANNX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

17:10 13-05-2026

Annexon, Inc. (ANNX) Presents at Bank of America Global Healthcare Conference 2026 Transcript...

Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones

Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones

16:01 07-05-2026

Topline Pivotal Phase 3 Data for Vonaprument for the Treatment of Geographic Atrophy (GA) Expected Q...

Annexon to Present at the Bank of America Securities Health Care Conference 2026

Annexon to Present at the Bank of America Securities Health Care Conference 2026

8:00 06-05-2026

BRISBANE, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical...

Annexon CEO Touts “Win Year” 2026 at Needham, Eyes GA Phase III Data and GBS FDA Filing

Annexon CEO Touts “Win Year” 2026 at Needham, Eyes GA Phase III Data and GBS FDA Filing

3:31 17-04-2026

Annexon (NASDAQ: ANNX) President and CEO Doug Love outlined a series of anticipated clinical and reg...

Annexon (NASDAQ:ANNX) Shares Down 6.1% – Should You Sell?

Annexon (NASDAQ:ANNX) Shares Down 6.1% – Should You Sell?

4:10 12-04-2026

Shares of Annexon, Inc. (NASDAQ: ANNX - Get Free Report) traded down 6.1% on Friday. The company tra...

Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference

Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference

16:05 08-04-2026

BRISBANE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutic...

Wall Street Analysts See a 165.52% Upside in Annexon (ANNX): Can the Stock Really Move This High?

Wall Street Analysts See a 165.52% Upside in Annexon (ANNX): Can the Stock Really Move This High?

10:55 01-04-2026

The mean of analysts' price targets for Annexon (ANNX) points to a 165.5% upside in the stock. While...

Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

16:01 30-03-2026

ARCHER II Topline Pivotal Phase 3 Data in Geographic Atrophy (GA) Expected Q4 2026; Vonaprument has ...

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

16:05 16-03-2026

BRISBANE, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceuti...

Annexon, Inc. (NASDAQ:ANNX) Receives $17.00 Average Target Price from Analysts

Annexon, Inc. (NASDAQ:ANNX) Receives $17.00 Average Target Price from Analysts

2:32 05-03-2026

Annexon, Inc. (NASDAQ: ANNX - Get Free Report) has been assigned an average recommendation of "Moder...

Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference

Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference

8:00 24-02-2026

BRISBANE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutica...

Insider Selling: Annexon (NASDAQ:ANNX) Insider Sells $26,979.00 in Stock

Insider Selling: Annexon (NASDAQ:ANNX) Insider Sells $26,979.00 in Stock

5:36 23-02-2026

Annexon, Inc. (NASDAQ: ANNX - Get Free Report) insider Jamie Dananberg sold 5,290 shares of Annexon ...

Annexon (NASDAQ:ANNX) EVP Sells $26,979.00 in Stock

Annexon (NASDAQ:ANNX) EVP Sells $26,979.00 in Stock

5:36 23-02-2026

Annexon, Inc. (NASDAQ: ANNX - Get Free Report) EVP Dean Richard Artis sold 5,290 shares of the firm'...

Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy

Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy

8:00 17-02-2026

BRISBANE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutica...

Annexon Offers A High-Risk, High-Reward Play On A New Approach To Complement-Mediated Diseases

Annexon Offers A High-Risk, High-Reward Play On A New Approach To Complement-Mediated Diseases

2:08 24-01-2026

Annexon offers high-risk, high-reward potential with its C1q-targeted pipeline, led by tanruprubart ...

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

17:05 16-01-2026

BRISBANE, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutica...

Annexon, Inc. (ANNX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Annexon, Inc. (ANNX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

17:06 14-01-2026

Annexon, Inc. (ANNX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript...

Annexon Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026

Annexon Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026

7:00 12-01-2026

Tanruprubart MAA Filed with Potential to Be the First Targeted Fast-Acting Therapy for  Guillain-Ba...

close

ANNEXON REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(C)(4)

16-01-2026
BRISBANE, CALIF., JAN. 16, 2026 (GLOBE NEWSWIRE) -- ANNEXON, INC. (NASDAQ: ANNX), A BIOPHARMACEUTICA...
Více zde

ANNEXON ACCELERATING NEXT GENERATION TARGETED IMMUNOTHERAPY PLATFORM FOR TREATMENT OF NEUROINFLAMMATORY DISEASES WITH MULTIPLE REGISTRATIONAL MILESTONES IN 2026

12-01-2026
TANRUPRUBART MAA FILED WITH POTENTIAL TO BE THE FIRST TARGETED FAST-ACTING THERAPY FOR  GUILLAIN-BA...
Více zde

ANNEXON SUBMITS TANRUPRUBART MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY FOR GUILLAIN-BARRÉ SYNDROME

08-01-2026
POTENTIAL TO BE THE FIRST TARGETED FAST-ACTING THERAPY FOR GBS, SETTING A NEW STANDARD OF CARE BLA S...
Více zde

ANNEXON BIOSCIENCES TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

07-01-2026
BRISBANE, CALIF., JAN. 07, 2026 (GLOBE NEWSWIRE) -- ANNEXON, INC. (NASDAQ: ANNX), A BIOPHARMACEUTICA...
Více zde

ANNEXON REPORTS INDUCEMENT GRANT TO NEW EMPLOYEE UNDER NASDAQ LISTING RULE 5635(C)(4)

16-12-2025
BRISBANE, CALIF., DEC. 16, 2025 (GLOBE NEWSWIRE) -- ANNEXON, INC. (“ANNEXON”) (NASDAQ: ANNX), A ...
Více zde

ANNEXON ANNOUNCES CLOSING OF PUBLIC OFFERING AND FULL EXERCISE OF UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL SHARES FOR GROSS PROCEEDS OF $86.25 MILLION

14-11-2025
BRISBANE, CALIF., NOV. 14, 2025 (GLOBE NEWSWIRE) -- ANNEXON, INC. (“ANNEXON”) (NASDAQ: ANNX), A ...
Více zde

ANNEXON ANNOUNCES PRICING OF $75 MILLION PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

12-11-2025
BRISBANE, CALIF., NOV. 12, 2025 (GLOBE NEWSWIRE) -- ANNEXON, INC. (“ANNEXON”) (NASDAQ: ANNX), A ...
Více zde

ANNEXON ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

12-11-2025
BRISBANE, CALIF., NOV. 12, 2025 (GLOBE NEWSWIRE) -- ANNEXON, INC. (NASDAQ: ANNX), A BIOPHARMACEUTICA...
Více zde

ANNEXON REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS, PORTFOLIO PROGRESS AND KEY ANTICIPATED MILESTONES

10-11-2025
LATE-STAGE NEUROINFLAMMATION PLATFORM ADVANCING GLOBAL REGISTRATIONAL PROGRAMS IN  GUILLAIN-BARRÉ ...
Více zde

ANNEXON REPORTS INDUCEMENT GRANT TO NEW EMPLOYEE UNDER NASDAQ LISTING RULE 5635(C)(4)

18-08-2025
BRISBANE, CALIF., AUG. 18, 2025 (GLOBE NEWSWIRE) -- ANNEXON, INC. (NASDAQ: ANNX), A BIOPHARMACEUTIC...
Více zde

ANNEXON REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS, PORTFOLIO PROGRESS AND KEY ANTICIPATED MILESTONES

14-08-2025
TANRUPRUBART (FORMERLY ANX005) FOR GBS ADVANCING THROUGH REGULATORY INTERACTIONS; MAA SUBMISSION IN ...
Více zde

ANNEXON SELECTED BY EMA TO PARTICIPATE IN PRODUCT DEVELOPMENT COORDINATOR PILOT FOR VONAPRUMENT (ANX007) FOR DRY AGE-RELATED MACULAR DEGENERATION WITH GEOGRAPHIC ATROPHY

07-08-2025
NEW PILOT APPOINTS DESIGNATED PRODUCT DEVELOPMENT COORDINATOR TO NAVIGATE REGULATORY INTERACTIONS, R...
Více zde

ANNEXON ANNOUNCES COMPLETION OF ENROLLMENT IN PIVOTAL PHASE 3 ARCHER II TRIAL OF VONAPRUMENT (FORMERLY ANX007) FOR DRY AGE-RELATED MACULAR DEGENERATION (AMD) WITH GEOGRAPHIC ATROPHY

24-07-2025
EXPEDITED ENROLLMENT SURPASSING 630 TARGETED PARTICIPANTS UNDERSCORES THE STRONG DEMAND FOR A THERAP...
Více zde

ANNEXON BOLSTERS OPHTHALMOLOGY EXPERTISE WITH APPOINTMENT OF RETINA SPECIALIST LLOYD CLARK, M.D., AS PIVOTAL ANX007 PROGRAM ADVANCES IN DRY AGE-RELATED MACULAR DEGENERATION (AMD) WITH GEOGRAPHIC ATROPHY (GA)

18-06-2025
DR. CLARK BRINGS 25 YEARS OF EXPERIENCE TREATING RETINA DISEASES AND DEVELOPING EMERGING THERAPIES A...
Více zde

ANNEXON BIOSCIENCES TO PRESENT AT THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE

29-05-2025
BRISBANE, CALIF., MAY 29, 2025 (GLOBE NEWSWIRE) -- ANNEXON, INC. (NASDAQ: ANNX), A BIOPHARMACEUTICAL...
Více zde

ANNEXON SHOWCASES TANRUPRUBART DATA DEMONSTRATING IMPROVED CLINICAL OUTCOMES IN GUILLAIN-BARRÉ SYNDROME (GBS) AT 2025 PERIPHERAL NERVE SOCIETY (PNS) ANNUAL MEETING

19-05-2025
FIRST ORAL PRESENTATION OF THE TANRUPRUBART REAL-WORLD EVIDENCE (RWE) STUDY BY INTERNATIONAL GUILLAI...
Více zde

ANNEXON REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(C)(4)

16-05-2025
BRISBANE, CALIF., MAY 16, 2025 (GLOBE NEWSWIRE) -- ANNEXON, INC. (NASDAQ: ANNX), A BIOPHARMACEUTICAL...
Více zde

ANNEXON REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS, PORTFOLIO PROGRESS AND KEY ANTICIPATED MILESTONES

12-05-2025
FDA MEETING FOR TANRUPRUBART (FORMERLY ANX005), THE FIRST POTENTIAL TARGETED THERAPY FOR GBS, SCHEDU...
Více zde

ANNEXON ANNOUNCES PRESENTATIONS ON THE CLINICAL ADVANCEMENT OF TANRUPRUBART AS THE FIRST POTENTIAL TARGETED THERAPY FOR GUILLAIN-BARRÉ SYNDROME (GBS) AT THE 2025 PNS MEETING

09-05-2025
FIRST ORAL PRESENTATION BY THE INTERNATIONAL GUILLAIN-BARRÉ SYNDROME OUTCOMES STUDY (IGOS) OF THE R...
Více zde

ANNEXON TO PRESENT ON THE NEUROPROTECTIVE EFFECTS OF ANX007 AT THE 2025 ARVO ANNUAL MEETING AND THE RETINA WORLD CONGRESS

07-05-2025
PHASE 2 ARCHER DATA SUPPORT THERAPEUTIC POTENTIAL FOR ANX007 TO PRESERVE VISION IN PATIENTS WHO HAVE...
Více zde

ANNEXON REPORTS INDUCEMENT GRANT TO NEW EMPLOYEE UNDER NASDAQ LISTING RULE 5635(C)(4)

16-04-2025
BRISBANE, CALIF., APRIL 16, 2025 (GLOBE NEWSWIRE) -- ANNEXON, INC. (NASDAQ: ANNX), A BIOPHARMACEUTIC...
Více zde

ANNEXON HIGHLIGHTS PIVOTAL DATA ON FIRST POTENTIAL TARGETED THERAPY FOR GUILLAIN-BARRÉ SYNDROME (GBS) AND SHOWCASES NEW GBS EDUCATION CAMPAIGN AT AMERICAN ACADEMY OF NEUROLOGY (AAN) 2025 ANNUAL MEETING

08-04-2025
ORAL PRESENTATION FEATURES PHASE 3 DATA SHOWING RAPID RECOVERY AND DURABLE BENEFIT OF TANRUPRUBART (...
Více zde

ANNEXON HIGHLIGHTS LEADERSHIP IN ADVANCING CLINICAL RESEARCH AND EDUCATION FOR GUILLAIN-BARRÉ SYNDROME (GBS) AT AMERICAN ACADEMY OF NEUROLOGY (AAN) 2025 ANNUAL MEETING

03-04-2025
ORAL PLENARY PRESENTATION ON TUESDAY, APRIL 8 FEATURES PHASE 3 DATA FOR ANX005, THE FIRST POTENTIAL ...
Více zde

ANNEXON REPORTS INDUCEMENT GRANT TO NEW EMPLOYEE UNDER NASDAQ LISTING RULE 5635(C)(4)

17-03-2025
BRISBANE, CALIF., MARCH 17, 2025 (GLOBE NEWSWIRE) -- ANNEXON, INC. (NASDAQ: ANNX), A BIOPHARMACEUTIC...
Více zde

ANNEXON REPORTS FOURTH QUARTER AND YEAR-END 2024 FINANCIAL RESULTS, PORTFOLIO PROGRESS AND KEY ANTICIPATED MILESTONES

03-03-2025
ROBUST, CONSISTENT PHASE 3 DATA AND REAL-WORLD EVIDENCE OUTCOMES SUPPORT ANX005 AS POTENTIAL FIRST T...
Více zde

ANNEXON BIOSCIENCES TO PRESENT AT THE TD COWEN 45TH ANNUAL HEALTH CARE CONFERENCE

26-02-2025
BRISBANE, CALIF., FEB. 26, 2025 (GLOBE NEWSWIRE) -- ANNEXON, INC. (NASDAQ: ANNX), A BIOPHARMACEUTIC...
Více zde

ANNEXON REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(C)(4)

18-02-2025
BRISBANE, CALIF., FEB. 18, 2025 (GLOBE NEWSWIRE) -- ANNEXON, INC. (NASDAQ: ANNX), A BIOPHARMACEUTICA...
Více zde

ANNEXON ANNOUNCES PRESENTATIONS HIGHLIGHTING ANX007 FUNCTIONAL AND STRUCTURAL DIFFERENTIATION IN GEOGRAPHIC ATROPHY AT THE MACULA SOCIETY 48TH ANNUAL MEETING

13-02-2025
BRISBANE, CALIF., FEB. 13, 2025 (GLOBE NEWSWIRE) -- ANNEXON, INC. (NASDAQ: ANNX), A BIOPHARMACEUTICA...
Více zde

ANNEXON BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

07-01-2025
BRISBANE, CALIF., JAN. 07, 2025 (GLOBE NEWSWIRE) -- ANNEXON, INC. (NASDAQ: ANNX), A BIOPHARMACEUTICA...
Více zde

ANNEXON REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(C)(4)

16-12-2024
BRISBANE, CALIF., DEC. 16, 2024 (GLOBE NEWSWIRE) -- ANNEXON, INC. (NASDAQ: ANNX), A BIOPHARMACEUTICA...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-14 00:00:008-KStáhnout
2026-01-12 00:00:008-KStáhnout
2025-11-14 00:00:008-KStáhnout
2025-11-10 00:00:008-KStáhnout
2025-11-10 00:00:0010-QStáhnout
2025-08-14 01:00:008-KStáhnout
2025-08-14 01:00:0010-QStáhnout
2025-08-14 00:00:008-KStáhnout
2025-08-14 00:00:0010-QStáhnout
2025-06-25 01:00:008-KStáhnout
2025-06-25 00:00:008-KStáhnout
2025-06-09 01:00:008-KStáhnout
2025-06-09 00:00:008-KStáhnout
2025-05-12 01:00:008-KStáhnout
2025-05-12 01:00:0010-QStáhnout
2025-05-12 00:00:008-KStáhnout
2025-05-12 00:00:0010-QStáhnout
2025-03-03 00:00:008-KStáhnout
2025-03-03 00:00:0010-KStáhnout
2025-03-02 23:00:008-KStáhnout
2025-03-02 23:00:0010-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2025-01-10 00:00:008-KStáhnout
2025-01-09 23:00:008-KStáhnout
2024-12-16 00:00:008-KStáhnout
2024-12-15 23:00:008-KStáhnout
2024-11-14 00:00:008-KStáhnout
2024-11-14 00:00:0010-QStáhnout
2024-11-13 23:00:008-KStáhnout
2024-11-13 23:00:0010-QStáhnout
2024-10-22 01:00:008-KStáhnout
2024-10-22 00:00:008-KStáhnout
2024-08-12 01:00:008-KStáhnout
2024-08-12 01:00:0010-QStáhnout
2024-08-12 00:00:008-KStáhnout
2024-08-12 00:00:0010-QStáhnout
2024-08-05 01:00:008-KStáhnout
2024-08-05 00:00:008-KStáhnout
2024-06-25 01:00:008-KStáhnout
2024-06-25 00:00:008-KStáhnout
2024-06-12 01:00:008-KStáhnout
2024-06-12 00:00:008-KStáhnout
2024-06-07 01:00:008-KStáhnout
2024-06-07 00:00:008-KStáhnout
2024-06-04 01:00:008-KStáhnout
2024-06-04 00:00:008-KStáhnout
2024-05-13 01:00:008-KStáhnout
2024-05-13 01:00:0010-QStáhnout
2024-05-13 00:00:008-KStáhnout
2024-05-13 00:00:0010-QStáhnout
2024-05-07 01:00:008-KStáhnout
2024-05-07 00:00:008-KStáhnout
2024-03-26 00:00:008-KStáhnout
2024-03-26 00:00:0010-KStáhnout
2024-03-25 23:00:008-KStáhnout
2024-03-25 23:00:0010-KStáhnout
2024-03-04 00:00:008-KStáhnout
2024-03-03 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-12-21 00:00:008-KStáhnout
2023-12-20 23:00:008-KStáhnout
2023-12-20 00:00:008-KStáhnout
2023-12-19 23:00:008-KStáhnout
2023-11-13 00:00:008-KStáhnout
2023-11-13 00:00:0010-QStáhnout
2023-11-12 23:00:008-KStáhnout
2023-11-12 23:00:0010-QStáhnout
2023-10-24 01:00:008-KStáhnout
2023-10-24 00:00:008-KStáhnout
2023-10-11 01:00:008-KStáhnout
2023-10-11 00:00:008-KStáhnout
2023-08-07 01:00:008-KStáhnout
2023-08-07 01:00:0010-QStáhnout
2023-08-07 00:00:008-KStáhnout
2023-08-07 00:00:0010-QStáhnout
2023-07-31 01:00:008-KStáhnout
2023-07-31 00:00:008-KStáhnout
2023-06-09 01:00:008-KStáhnout
2023-06-09 00:00:008-KStáhnout
2023-05-25 01:00:008-KStáhnout
2023-05-25 00:00:008-KStáhnout
2023-05-08 01:00:008-KStáhnout
2023-05-08 01:00:0010-QStáhnout
2023-05-08 00:00:008-KStáhnout
2023-05-08 00:00:0010-QStáhnout
2023-03-13 00:00:008-KStáhnout
2023-03-12 23:00:008-KStáhnout
2023-03-06 00:00:008-KStáhnout
2023-03-06 00:00:0010-KStáhnout
2023-03-05 23:00:008-KStáhnout
2023-03-05 23:00:0010-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2023-01-06 00:00:008-KStáhnout
2023-01-05 23:00:008-KStáhnout
2022-11-03 00:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:008-KStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-08-08 01:00:008-KStáhnout
2022-08-08 01:00:0010-QStáhnout
2022-08-08 00:00:008-KStáhnout
2022-08-08 00:00:0010-QStáhnout
2022-07-08 01:00:008-KStáhnout
2022-07-08 00:00:008-KStáhnout
2022-06-10 01:00:008-KStáhnout
2022-06-10 00:00:008-KStáhnout
2022-06-07 01:00:008-KStáhnout
2022-06-07 00:00:008-KStáhnout
2022-05-09 01:00:008-KStáhnout
2022-05-09 01:00:0010-QStáhnout
2022-05-09 00:00:008-KStáhnout
2022-05-09 00:00:0010-QStáhnout
2022-04-07 01:00:008-KStáhnout
2022-04-07 00:00:008-KStáhnout
2022-03-01 00:00:008-KStáhnout
2022-03-01 00:00:0010-KStáhnout
2022-02-28 23:00:008-KStáhnout
2022-02-28 23:00:0010-KStáhnout
2022-02-22 00:00:008-KStáhnout
2022-02-21 23:00:008-KStáhnout
2022-02-03 00:00:008-KStáhnout
2022-02-02 23:00:008-KStáhnout
2022-01-20 00:00:008-KStáhnout
2022-01-19 23:00:008-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2022-01-04 00:00:008-KStáhnout
2022-01-03 23:00:008-KStáhnout
2021-11-09 00:00:008-KStáhnout
2021-11-09 00:00:0010-QStáhnout
2021-11-08 23:00:008-KStáhnout
2021-11-08 23:00:0010-QStáhnout
2021-10-04 01:00:008-KStáhnout
2021-10-04 00:00:008-KStáhnout
2021-08-16 01:00:008-KStáhnout
2021-08-16 01:00:0010-QStáhnout
2021-08-16 00:00:008-KStáhnout
2021-08-16 00:00:0010-QStáhnout
2021-07-22 01:00:008-KStáhnout
2021-07-22 00:00:008-KStáhnout
2021-06-08 01:00:008-KStáhnout
2021-06-08 00:00:008-KStáhnout
2021-05-17 01:00:008-KStáhnout
2021-05-17 01:00:0010-QStáhnout
2021-05-17 00:00:008-KStáhnout
2021-05-17 00:00:0010-QStáhnout
2021-03-25 00:00:008-KStáhnout
2021-03-25 00:00:0010-KStáhnout
2021-03-24 23:00:008-KStáhnout
2021-03-24 23:00:0010-KStáhnout
2021-03-01 00:00:008-KStáhnout
2021-02-28 23:00:008-KStáhnout
2021-02-08 00:00:008-KStáhnout
2021-02-07 23:00:008-KStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2020-12-22 00:00:008-KStáhnout
2020-12-21 23:00:008-KStáhnout
2020-11-16 00:00:008-KStáhnout
2020-11-16 00:00:0010-QStáhnout
2020-11-15 23:00:008-KStáhnout
2020-11-15 23:00:0010-QStáhnout
2020-09-08 01:00:008-KStáhnout
2020-09-08 01:00:0010-QStáhnout
2020-09-08 00:00:008-KStáhnout
2020-09-08 00:00:0010-QStáhnout
2020-07-28 01:00:008-KStáhnout
2020-07-28 00:00:008-KStáhnout
preloader